Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

Source:http://linkedlifedata.com/resource/pubmed/id/17317837

Clin. Cancer Res. 2007 Feb 15 13 4 1253-9

Download in:

View as

Triples

General Info

PMID
17317837